PRF Technologies (PRFX) Cash & Equivalents (2019 - 2026)
PRF Technologies' (PRFX) quarterly Cash & Equivalents came in at $8.5 million in Q2 2026, up 144.02% on a YoY basis from $3.5 million in Q2 2025, and up 172.83% quarter-over-quarter from $3.1 million in Q4 2025.
Powered by 
Analysis
PRF Technologies (PRFX) Cash & Equivalents (2019 - 2026) Analysis & Trends
PRF Technologies (PRFX) has reported Cash & Equivalents for 8 consecutive years, with $8.5 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Cash & Equivalents rose 144.02% year-over-year to $8.5 million; the trailing twelve-month figure through Jun 2026 stood at $8.5 million (up 144.02% YoY), and the FY2025 full-year result was $3.1 million, down 26.66% from the prior year.
- Cash & Equivalents grew to $8.5 million in Q2 2026 per PRFX's latest filing, from $3.1 million in the prior quarter.
- Across five years, Cash & Equivalents topped out at $16.6 million in Q1 2022 and bottomed at $2.8 million in Q2 2024.
- Historically, Cash & Equivalents has averaged $6.9 million across 5 years, with a median of $6.0 million in 2022.
- The sharpest annual moves came in 2022 and 2026: Cash & Equivalents plunged 75.23% in 2022, then soared 144.02% in 2026.
- Over 5 years, Cash & Equivalents stood at $4.1 million in 2022, then surged by 95.95% to $8.0 million in 2023, then plunged by 46.91% to $4.3 million in 2024, then retreated by 26.66% to $3.1 million in 2025, then jumped by 172.83% to $8.5 million in 2026.
- According to Business Quant data, Cash & Equivalents over the past three periods registered $8.5 million, $3.1 million, and $3.5 million for Q2 2026, Q4 2025, and Q2 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 46.72 Bn | 43.07 Bn | 2.15 Bn | 3.66 Bn |
| 2 | Viatris | 19.64 Bn | 18.75 Bn | 1.46 Bn | 886.50 Mn |
| 3 | Dr Reddys Laboratories | 10.36 Bn | 10.22 Bn | 396.53 Mn | 118.35 Mn |
| 4 | Amneal Pharmaceuticals | 6.44 Bn | 6.39 Bn | 334.51 Mn | 127.64 Mn |
| 5 | Bausch Health Companies | 2.11 Bn | 1.24 Bn | 2.10 Bn | 1.83 Bn |
| 6 | Ani Pharmaceuticals | 1.88 Bn | 1.52 Bn | 165.89 Mn | 360.21 Mn |
| 7 | Alvotech | 1.83 Bn | 1.69 Bn | 2.56 Mn | 142.75 Mn |
| 8 | Amphastar Pharmaceuticals | 1.04 Bn | 751.07 Mn | 93.47 Mn | 223.61 Mn |
| 9 | Fennec Pharmaceuticals | 382.22 Mn | 340.97 Mn | 17.15 Mn | 41.25 Mn |
| 10 | PRF Technologies | 622,054.07 | -10.31 Mn | - | 8.53 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.53 Mn |
| Dec 31, 2025 | 3.13 Mn |
| Jun 30, 2025 | 3.49 Mn |
| Dec 31, 2024 | 4.26 Mn |
| Jun 30, 2024 | 2.79 Mn |
| Mar 31, 2024 | 4.32 Mn |
| Dec 31, 2023 | 8.03 Mn |
| Sep 30, 2023 | 7.55 Mn |
| Jun 30, 2023 | 5.15 Mn |
| Mar 31, 2023 | 8.15 Mn |
| Dec 31, 2022 | 4.10 Mn |
| Sep 30, 2022 | 6.95 Mn |
| Jun 30, 2022 | 13.87 Mn |
| Mar 31, 2022 | 16.57 Mn |
| Dec 31, 2021 | 16.54 Mn |
| Sep 30, 2021 | 18.34 Mn |
| Jun 30, 2021 | 17.80 Mn |
| Mar 31, 2021 | 19.44 Mn |
| Dec 31, 2020 | 15.68 Mn |
| Sep 30, 2020 | 17.72 Mn |
API Access
PRF Technologies Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=PRFX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "PRFX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=PRFX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();